This article is included in these additional categories:

Biological Weapons | Contracts - Awards | Design Innovations | Medical | Other Corporation | R&D - Contracted | USA | WMD Defenses

US Funds Novel Anti-Bacterial Research at PolyMedix

For more on this and other stories, please consider purchasing a membership.
If you are already a subscriber, login to your account.
PolyMedix of Radnor, PA has now received 3 biodefense-related contracts from the US government, including a a $1.6 million, 1-year contract from the US Defense Threat Reduction Agency (DTRA) to develop new “defensin-mimetic antibiotic compounds.” The primary goal of that contract is to devise more effective rapid-response countermeasures against anthrax, plague, and tularemia. Other work […]

One Source: Hundreds of programs; Thousands of links, photos, and analyses

DII brings a complete collection of articles with original reporting and research, and expert analyses of events to your desktop – no need for multiple modules, or complex subscriptions. All supporting documents, links, & appendices accompany each article.

Benefits

  • Save time
  • Eliminate your blind spots
  • Get the big picture, quickly
  • Keep up with the important facts
  • Stay on top of your projects or your competitors

Features

  • Coverage of procurement and doctrine issues
  • Timeline of past and future program events
  • Comprehensive links to other useful resources